Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SXT | New code LPE from now on - please switch to LPE | 29/12/15 | 3 | 3.5K | |||
|
|||||||
SXT | Ann: Becoming a substantial holder | 23/12/15 | 0 | 904 | |||
|
|||||||
SXT | Ann: LPE Acquisition and Requotation Update | 23/12/15 | 3 | 2.6K | |||
|
|||||||
SXT | Come on ASX | 22/12/15 | 0 | 656 | |||
|
|||||||
SXT | Ann: Initial Director's Interest Notice x 2 | 21/12/15 | 4 | 3.0K | |||
|
|||||||
SXT | Ann: Final Director's Interest Notice x 2 | 21/12/15 | 4 | 2.4K | |||
|
|||||||
SXT | Ann: Change of Director's Interest Notice | 18/12/15 | 0 | 711 | |||
|
|||||||
SXT | Ann: SXT Successfully Completes $6m Raise | 18/12/15 | 28 | 14K | |||
|
See All Discussions